Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1077 of 5804
-
Could adding common diabetes pills improve type 1 control?
Disease control Recruiting nowThis will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual car…
Sponsor: Indiana University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye drop could ease severe allergy in kids
Disease control Recruiting nowThe aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could less be more? new trial tests lower drug dose to tame myeloma side effects
Disease control Recruiting nowThis phase I/II trial evaluates the safety and feasibility of early, response-based dose reduction of linvoseltamab in the treatment of patients multiple myeloma that has come back after a period of improvement (relapsed), that does not respond to treatment (refractory), or that …
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Warm baths may boost heart health for spinal injury patients
Disease control Recruiting nowThe study is designed to investigate the effects of passive heat therapy on blood vessel health in 40 people (48 enrolled with attrition rate of 20%). Following an extensive set of vascular function tests, participants will engage in either a passive heat therapy intervention for…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to tame kidney cancer
Disease control Recruiting nowTo find out if the combination of HC-7366 and nivolumab (with or without ipilimumab) can help to control ccRCC. The
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New shot aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThe purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a drug calm heart inflammation in people with TET2 mutations?
Disease control Recruiting nowThe primary goal of this clinical trial is to test the hypothesis that the drug canakinumab (anti-IL-1B monoclonal antibody) decreases vascular inflammation when used by people with a history of coronary artery disease, including those with and without clonal hematopoiesis driven…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New wireless catheter could spot hidden heart disease in chest pain patients
Diagnosis Not yet recruitingThis study aims to evaluate the sensitivity and specificity of a multi-sensor wireless pressure microcatheter for the diagnosis of CMD in patients with ANOCA/INOCA, using quantitative myocardial perfusion imaging of cardiac magnetic resonance (CMR) as a reference.
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New dissolving film could tame dust mite allergies without shots
Disease control Not yet recruitingTo evaluate the efficacy and safety of different doses of Sublingual Film for Dermatophagoides Pteronyssinus in adult patients with Dust Mite Allergic Rhinitis via a randomized, double-blind, placebo-controlled Phase II clinical trial, and to explore the optimal dose for the Phas…
Phase: PHASE2 • Sponsor: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Good bacteria vs. bad: new trial aims to stop BV from coming back
Disease control Not yet recruitingRecurrent bacterial vaginosis is a common condition in women of reproductive age and is characterized by a disruption of the normal vaginal microbiota, with a reduction in Lactobacillus species and an overgrowth of anaerobic bacteria such as Gardnerella vaginalis. Recurrence rate…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
ECMO breakthrough? major trial aims to cut deadly complications
Knowledge-focused Recruiting nowThe goal of this platform trial is to determine the efficacy, safety and cost-effectiveness of various interventions in patients with acute cardiorespiratory failure requiring extracorporeal membrane oxygenation (ECMO) The main question the platform trial aims to address is to d…
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New antibody aims to tame lupus by targeting troublemaking cells
Disease control Recruiting nowThis Phase 1, open label, dose escalation study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of HB2198, a tetravalent bispecific anti CD19/CD20 antibody, in adults with moderately to severely active systemic lupus eryth…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New PET scan could spot hidden endometriosis lesions
Diagnosis Recruiting nowDiagnostic wandering is one of the characteristics of endometriosis due to great anatomical and clinical variability but also due to poorly relevant diagnostic examinations. \[18F\]-FES PET/CT could on the one hand improve diagnosis by showing greater sensitivity than MRI and on …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a selfie replace the Finger-Prick? new study tests facial scan for diabetes screening
Diagnosis Not yet recruitingThe goal of this observational study is to evaluate whether a non-invasive facial scan technology using remote photoplethysmography (rPPG) can accurately estimate blood glucose and HbA1c levels in adults living in the community in Jakarta. The study focuses on adults aged 18 year…
Sponsor: Tarumanagara University • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
New heart valve fix without open surgery: early trial begins
Disease control Recruiting nowThe goal of this early feasibility clinical trial is to test a new device called the MitraFix® Transcatheter Mitral Valve System. It aims to learn if the device is safe and if it can help adults who have a severe leaky heart valve (mitral regurgitation). This study is for people …
Phase: NA • Sponsor: Mitrassist Lifesciences Limited Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New CAR-T therapy aims to tackle tough lymphoma
Disease control Not yet recruitingThis single-arm, open-label pilot study will assess the safety and efficacy of RN1701, a bispecific CD19/CD20-targeted allogeneic CAR-T-cell product, in patients with relapsed or refractory B-cell lymphoma. Up to 19 participants will be enrolled in a conventional 3 + 3 dose-escal…
Phase: PHASE1, PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New program aims to help chinese american smokers quit and clean up toxic smoke residue
Disease control Recruiting nowThis study evaluates whether the Smokefree Family Living (SFL) intervention improves quit rates (smoking cessation) and exposure to tobacco contamination that stays in items such as, carpets, walls, and furniture, even after the smoke has cleared (third-hand smoke (THS)) among Ch…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Penicillin break: major trial tests if kids with mild RHD can ditch daily antibiotics
Disease control Recruiting nowGOAL-Stop is a randomized, controlled, non-inferiority trial designed to evaluate whether discontinuing secondary antibiotic prophylaxis (SAP) is non-inferior to continuing SAP in preventing progression of rheumatic heart disease (RHD) among children and adolescents. The trial wi…
Phase: PHASE3 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New kidney drug shows promise in reducing protein leakage
Disease control Recruiting nowThis study is open to adults with certain kidney conditions, including secondary focal segmental glomerulosclerosis (sFSGS), treatment-resistant primary minimal change disease (TR-pMCD), Alport Syndrome (AS), and treatment-resistant primary membranous nephropathy (TR-pMN). Adoles…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart stent study aims to ease stiff heart symptoms
Symptom relief Recruiting nowHFpEF (heart failure with preserved ejection fraction) is a condition in which the heart muscle becomes stiff and can't pump blood properly. People living with HFpEF also often have coronary artery disease, where the blood vessels that supply the heart are narrowed or blocked. I…
Phase: PHASE2 • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC